Flu Clinical Studies & Case Reports

Avian influenza, listed by the World Organization for Animal Health (OIE), has become a disease of great importance for animal and human health.Millions of animals have died, and concern is growing over the loss of human lives and management of the pandemic potential. Vaccinology for avian influenza is critical. Birds receiving a primary vaccination with Ad-NP+M1 and a secondary vaccination with MVA-NP+M1 exhibited reduced cloacal shedding as measured by plaque assay at 7 days post infection compared with birds vaccinated with recombinant viruses containing irrelevant antigen.  Since 2002, various wild bird species also have succumbed to infection with the Eurasian H5N1 HPAI viruses. The pathogenesis of AI is complex and the ability of these viruses to produce disease and death in avian species. Importance of continued investigation of the pathobiology of both low- and HPAIV infections in wild birds which is essential in the understanding of their epidemiology and, in turn, can contribute to the design and implementation of preventive and control measures to protect the health of humans and animals. The spread of swine flu around the world was classed by the World Health Organization (WHO) as a global pandemic. After 6 July 2009, the WHO stopped producing detailed worldwide figures. The WHO GISRS laboratories tested more than 39 635 specimens. 2980 were positive for influenza viruses, of which 1044 (35%) were typed as influenza A and 1936 (65%) as influenza B. Of the sub-typed influenza A viruses, 359 (46.6%) were influenza A(H1N1)pdm09 and 412 (53.4%) were influenza A(H3N2). Of the characterized B viruses, 155 (95.1%) belonged to the B-Yamagata lineage and 8 (4.9%) to the B-Victoria lineage. Public awareness of the human health risks of zoonotic infections has grown in recent years. Currently, concern of H5N1 flu transmission from migratory bird populations has increased with foci of fatal human cases. This comes on the heels of other major zoonotic viral epidemics in the last decade.


 

Flu is a contagious respiratory illness caused by influenza viruses. Most people who get influenza will recover in a few days to less than two weeks, but some people will develop complications (such as pneumonia) which are life-threatening and result in death.The high morbidity and mortality associated with both pandemic and seasonal influenza and the anticipation for future influenza pandemics puts influenza front and center in infectious disease research. Vaccine efficacy refers to studies of vaccine effects that occur under randomized, controlled conditions, where individuals are randomly assigned to either a group that is given influenza vaccine or to a second group that is not given influenza vaccine. Vaccine effectiveness is a measure of how well influenza vaccines work to protect against influenza infection and illness when they are used in routine circumstances in the community, and not specifically in a RCT. The presence of chronic medical conditions may also affect the effectiveness of influenza vaccines.

  • Avian flu
  • Swine flu
  • Ebola
  • Influenza like illeness
  • Zoonotic infection
  • Interaction between Influenza and Pneumococcal
  • Virus-host interaction and co-infection
  • Chest infection and other respiratory infection along with flu
  • Travel medicine

Related Conference of Flu Clinical Studies & Case Reports

September 27-29, 2018

10th Euro-Global Conference on Infectious Diseases

Rome, Italy
(Holiday Inn Rome Eur Parco dei Medici)
November 12-13, 2018

11th Global Infections Conference

Melbourne, Australia
November 12-13, 2018

8th Asia Pacific STD and Infectious Diseases Congress

Hotel Radisson , Tokyo Japan
November 15-16, 2018

6th Annual Conference on Parasitology & Infectious Diseases

Istanbul, Turkey
November 22-23, 2018

8th International Conference on Bacteriology and Infectious Diseases

Cape Town, South Africa
December 05-06, 2018

6th International Conference On Infectious Diseases

Lisbon, Portugal
December 05-07, 2018

World Congress on Rare Diseases

Dubai, UAE
December 6-7, 2018

14th World Congress on Infection Prevention and Control

Valencia, Spain
Feb 25-26, 2019

6th International Congress on Infectious Diseases

London, United Kingdom
April 08-09, 2019

2nd Global experts meet on STD-AIDS and Infectious Diseases

Wellington, New Zealand
June 17-18, 2019

9th World Congress on Rare Diseases and Orphan Drugs

Berlin, Germany
July 29-30, 2019

Annual Meeting on Infectious Diseases

Amsterdam, Netherlands
September 16-17, 2019

10th International Conference on Emerging Infectious Diseases

Brussels, Belgium
September 23-24, 2019 Toronto, Canada

6th Annual Congress on Rare Diseases and Orphan Drugs

September 23-24, 2019

2nd Global Experts Meeting on Infectious Diseases

Tokyo, Japan

Flu Clinical Studies & Case Reports Conference Speakers